Curtailed two-stage matched pairs design in double-arm Phase II clinical trials

Area of Science:

• Clinical Trials
• Biostatistics
• Drug Development

Background:

• Phase II clinical trials are crucial for drug development but can be lengthy.
• Limited sample sizes and low success rates in trials for rare diseases pose significant challenges.

Purpose of the Study:

• To propose a novel curtailed two-stage matched pairs design for Phase II clinical trials.
• To accelerate the drug development process by enabling early trial termination or continuation based on interim results.

Main Methods:

• The proposed design utilizes the inverse trinomial distribution to establish decision rules.
• It involves two stages with defined cutoff points for trial assessment.
• The design focuses on matched pairs, comparing a treatment arm against a control arm.

Main Results:

• The design offers a method to efficiently utilize limited sample sizes.
• It provides a framework for making timely decisions on trial continuation or termination.
• The approach is particularly beneficial for studies with a low probability of success.

Conclusions:

• The curtailed two-stage matched pairs design can shorten drug development timelines.
• This innovative approach is well-suited for Phase II trials, especially those involving rare diseases or uncommon conditions.
• The inverse trinomial distribution provides a robust statistical basis for decision-making within the trial design.